Dec 4, 2025

Featuring an interview with Dr Matthew Lunning, including the following topics:

• Reflection on the advances made in chimeric antigen receptor (CAR) T-cell therapy (0:00)
• Overview of the CAR T-cell therapy administration process (4:40)
• Opportunities for referral for CAR T-cell therapy (10:05)
• Selection of a CAR T-cell...

Dec 4, 2025

Featuring a slide presentation and related discussion from Dr Matthew Lunning, including the following topics:

• Overview of available chimeric antigen receptor (CAR) T-cell therapies (0:00)
• Toxicities associated with CAR T-cell therapy (4:03)
• Mitigation strategies for adverse events (22:02)
• Novel strategies for...

Nov 15, 2025

Featuring perspectives from Dr Jeremy S Abramson and Dr Manali Kamdar, including the following topics: 

• Introduction: About This Program (0:00)
• Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (3:10)
• Potential Treatment Benefits of CAR T-Cell Therapy (10:35)
• CRS (Cytokine Release Syndrome) and ICANS (Immune...

Nov 13, 2025

Featuring perspectives from Dr Matthew Lunning and Dr Sonali M Smith, including the following topics: 

• Which Driver and Which Race: CAR-T and Bispecific Antibodies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Dr Lunning (0:00)
• Available and Emerging Novel Therapies for Diffuse...

Oct 23, 2025

Featuring an interview with Dr Eunice S Wang, including the following topics:

• Hypomethylating agent/venetoclax combinations for the treatment of acute myeloid leukemia (AML); integration in community practice (0:00)
• All-oral regimen of decitabine/cedazuridine with venetoclax for patients with newly diagnosed AML not...